Company Filing History:
Years Active: 2018-2019
Title: Lilley Leong: Innovator in Factor VIII Polypeptides
Introduction
Lilley Leong is a prominent inventor based in Hercules, California. She has made significant contributions to the field of biotechnology, particularly in the development of variant Factor VIII polypeptides. With a total of 2 patents, her work has the potential to impact therapeutic approaches for hemophilia and related disorders.
Latest Patents
Lilley Leong's latest patents focus on variant Factor VIII polypeptides and methods of their production and use. These disclosures detail polypeptides that include amino acid substitutions at critical sites, such as the thrombin cleavage site and the activation loop. The patents also explore additional substitutions within the A1-A2 and A2-A3 domain interfaces. Furthermore, the disclosures encompass methods for producing these polypeptides, as well as the nucleic acids encoding them, vectors, recombinant cells, and pharmaceutical compositions that utilize these innovations.
Career Highlights
Lilley Leong is currently associated with Bayer Healthcare LLC, where she continues to advance her research in biotechnology. Her work is instrumental in developing new therapeutic strategies that could enhance the efficacy of treatments for patients with bleeding disorders.
Collaborations
Lilley collaborates with esteemed colleagues, including Uwe Gritzan and Peter Kretschmer. These partnerships foster a dynamic research environment that encourages innovation and the sharing of ideas.
Conclusion
Lilley Leong's contributions to the field of biotechnology, particularly through her patents on variant Factor VIII polypeptides, highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for improving patient care in hemophilia treatment.